A Novel Fusion of TPR and ALK in Lung Adenocarcinoma
暂无分享,去创建一个
H. Peckham | Zongli Zheng | Joungho Han | Jhingook Kim | M. Hong | Yoon-La Choi | Mao Mao | So-Jung Choi | R. Kim | Ji-Young Song | Maruja Lira | D. Mann | Kinnari Pandy | Joshua A Stahl | Ji-Young Song | Joshua A. Stahl | Ji-Young Song
[1] Shibing Deng,et al. Multiplexed gene expression and fusion transcript analysis to detect ALK fusions in lung cancer. , 2013, The Journal of molecular diagnostics : JMD.
[2] Pinjun Wan,et al. Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome , 2012, Genes, chromosomes & cancer.
[3] D. Rekosh,et al. The Tpr protein regulates export of mRNAs with retained introns that traffic through the Nxf1 pathway. , 2011, RNA.
[4] Jeffrey W. Clark,et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. , 2010, The New England journal of medicine.
[5] J. Kutok,et al. Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] A. Reiter,et al. The 8p11 Myeloproliferative Syndrome: A Distinct Clinical Entity Caused by Constitutive Activation of FGFR1 , 2002, Acta Haematologica.
[7] B. Falini,et al. Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamycin. , 2002, Cancer research.
[8] Angela Greco,et al. The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium , 2000, Oncogene.
[9] S. Doxsey,et al. Functional Analysis of Tpr: Identification of Nuclear Pore Complex Association and Nuclear Localization Domains and a Role in mRNA Export , 1998, The Journal of cell biology.
[10] K. Pulford,et al. Nucleolar localization of the nucleophosmin-anaplastic lymphoma kinase is not required for malignant transformation. , 1998, Cancer research.
[11] E. Fey,et al. Product of the oncogene‐activating gene Tpr is a phosphorylated protein of the nuclear pore complex , 1996, Journal of cellular biochemistry.
[12] M. Pierotti,et al. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas. , 1992, Oncogene.
[13] E. Fuchs,et al. The molecular biology of intermediate filament proteins. , 1992, International review of cytology.
[14] G. Wogan,et al. The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[15] G. V. Vande Woude,et al. Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases. , 1988, Proceedings of the National Academy of Sciences of the United States of America.